Naresh Jain

Company: NJ Bio, Inc.

Job title: President & Chief Executive Officer

Seminars:

Accelerated Pathway From Antibody to ADC 10:15 am

The pathway from antibody to ADC is complex, resource intensive, and time-consuming There are numerous platform-based solutions including various payload classes, differing linker chemistries, and conjugation technologies to evaluate This talk will demonstrate how having high-quality material, expertize and the right technology can accelerate your ADC programsRead more

day: Day Two AM